SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001387131-16-005907
Filing Date
2016-06-27
Accepted
2016-06-27 16:53:05
Documents
4
Period of Report
2016-04-11
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDED CURRENT REPORT admp-8k_041116.htm 8-K/A 20128
2 CONSENT OF PUBLIC ACCOUNTING FIRM ex23-1.htm EX-23.1 7768
3 FINANCIAL STATEMENTS LISTED IN ITEM 9.01(A) ex99-1.htm EX-99.1 185411
4 PRO FORMA FINANCIAL INFORMATION LISTED IN ITEM 9.01(B) ex99-2.htm EX-99.2 77021
  Complete submission text file 0001387131-16-005907.txt   291516
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36242 | Film No.: 161733862
SIC: 2834 Pharmaceutical Preparations